Free tool
Stocks above their 200-day average
We cover 645 companies trading above their own 200-day average. The median market value in the group is $202.71M. Across the group, the median move over the past trading day is 0.00%. 100% of the 645 with a 200-day average trade above it. Price change over the past year runs from −27.2% to +197.1% across the middle 80 percent of the group, with a median of +23.7%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
645 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| 4591.T | Ribomic Inc. | $30.52M | Micro cap | −17.31% |
| NXN.AX | Nexsen Ltd | $30.21M | Micro cap | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | $30.10M | Micro cap | +27.08% |
| EYE.AX | Nova Eye Medical Limited | $29.60M | Micro cap | +3.45% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| 6545.T | internet infinity Inc. | $27.61M | Micro cap | +34.23% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | $27.33M | Micro cap | −15.04% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.92M | Micro cap | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $26.60M | Micro cap | +97.38% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| OSL.AX | OncoSil Medical Limited | $25.86M | Micro cap | +0.87% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| 4884.T | Kringle Pharma, Inc. | $22.30M | Micro cap | −11.29% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| 7129.T | Miahelsa Holdings Corporation | $20.31M | Micro cap | +4.87% |
| RHT.AX | Resonance Health Limited | $20.23M | Micro cap | +43.90% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| NOX.AX | Noxopharm Limited | $19.87M | Micro cap | −10.00% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| 9220.T | FB Care Service Co.,Ltd. | $19.37M | Micro cap | +11.55% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| 5619.T | MRSO INC | $18.85M | Micro cap | −16.43% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| ALINS.PA | Intrasense S.A. | $18.05M | Micro cap | −0.34% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.00M | Micro cap | +3.31% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | $16.52M | Micro cap | +18.10% |
| 6063.T | Emergency Assistance Japan Co., Ltd. | $15.79M | Micro cap | +0.89% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| BTC.AX | BTC Health Limited | $15.67M | Micro cap | −1.61% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| ORTI-B.ST | Ortivus AB (publ) | $15.21M | Micro cap | +42.11% |
| ICR.AX | Intelicare Holdings Limited | $14.91M | Micro cap | +75.76% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| OBSRV.OL | Observe Medical ASA | $14.28M | Micro cap | +5.05% |
| NTI.AX | Neurotech International Limited | $14.26M | Micro cap | +15.38% |
| 189A.T | D&M COMPANY CO LTD | $14.10M | Micro cap | +9.26% |
| 7083.T | AHC Group Inc. | $14.05M | Micro cap | +16.95% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| IDT.AX | IDT Australia Limited | $13.82M | Micro cap | −30.77% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $13.60M | Micro cap | −28.35% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| NXTCL.ST | NextCell Pharma AB | $12.42M | Micro cap | −5.10% |
| 6029.T | Artra Group Corporation | $12.41M | Micro cap | −19.57% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| ALAMA.PA | AMA Corporation Plc | $10.27M | Micro cap | −34.56% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.63M | Micro cap | −2.36% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| 7362.T | Terminalcare Support Institute Inc. | $8.43M | Micro cap | +3.53% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| PRE.MI | Predict S.p.A. | $8.17M | Micro cap | +7.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| PILA.ST | Pila Pharma AB (publ) | $7.79M | Micro cap | −15.41% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CODE.OL | CodeLab Capital AS | $7.42M | Micro cap | +22.74% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| 011000.KS | GeneOne Life Science, Inc. | $7.01M | Micro cap | +18.40% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +30.00% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +104.82% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| CTQ.AX | Careteq Limited | $6.32M | Micro cap | +20.00% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| STRAP.CO | Strategic Partners A/S | $5.82M | Micro cap | −28.50% |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| FLUI.ST | Fluicell AB (publ) | $5.06M | Micro cap | +247.74% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| AINO.ST | Aino Health AB (publ) | $4.25M | Micro cap | −10.81% |
| ADR.AX | Adherium Limited | $3.93M | Micro cap | +1900.00% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| MONSO.CO | Monsenso A/S | $3.14M | Micro cap | +23.81% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +15.79% |
| TD1.AX | TALi Digital Limited | $3.02M | Micro cap | −10.00% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| RESP.ST | Respiratorius AB (publ) | $1.89M | Micro cap | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | $1.71M | Micro cap | +22.47% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| ALINT.PA | IntegraGen SA | $1.38M | Micro cap | −36.25% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.